290 related articles for article (PubMed ID: 30213209)
1. Design of ciprofloxacin-loaded nano-and microcomposite particles for dry powder inhaler formulations: preparation, in vitro characterisation, and antimicrobial efficacy.
Topal GR; Devrim B; Eryilmaz M; Bozkir A
J Microencapsul; 2018 Sep; 35(6):533-547. PubMed ID: 30213209
[TBL] [Abstract][Full Text] [Related]
2. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation.
Yu H; Teo J; Chew JW; Hadinoto K
Int J Pharm; 2016 Feb; 499(1-2):38-46. PubMed ID: 26757148
[TBL] [Abstract][Full Text] [Related]
3. Optimization of a dry powder inhaler of ciprofloxacin-loaded polymeric nanomicelles by spray drying process.
Farhangi M; Mahboubi A; Kobarfard F; Vatanara A; Mortazavi SA
Pharm Dev Technol; 2019 Jun; 24(5):584-592. PubMed ID: 30431373
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations.
Devrim B; Bozkır A; Canefe K
Drug Dev Ind Pharm; 2011 Nov; 37(11):1376-86. PubMed ID: 21548727
[TBL] [Abstract][Full Text] [Related]
5. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity.
Jeong YI; Na HS; Seo DH; Kim DG; Lee HC; Jang MK; Na SK; Roh SH; Kim SI; Nah JW
Int J Pharm; 2008 Mar; 352(1-2):317-23. PubMed ID: 18160236
[TBL] [Abstract][Full Text] [Related]
6. Development of Inhalable Nanostructured Lipid Carriers for Ciprofloxacin for Noncystic Fibrosis Bronchiectasis Treatment.
Almurshedi AS; Aljunaidel HA; Alquadeib B; Aldosari BN; Alfagih IM; Almarshidy SS; Eltahir EKD; Mohamoud AZ
Int J Nanomedicine; 2021; 16():2405-2417. PubMed ID: 33814907
[TBL] [Abstract][Full Text] [Related]
7. Novel Inhalable Ciprofloxacin Dry Powders for Bronchiectasis Therapy: Mannitol-Silk Fibroin Binary Microparticles with High-Payload and Improved Aerosolized Properties.
Liu C; Lin L; Huang Z; Wu Q; Jiang J; Lv L; Yu X; Quan G; Li G; Wu C
AAPS PharmSciTech; 2019 Jan; 20(2):85. PubMed ID: 30673901
[TBL] [Abstract][Full Text] [Related]
8. Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach.
Karimi K; Pallagi E; Szabó-Révész P; Csóka I; Ambrus R
Drug Des Devel Ther; 2016; 10():3331-3343. PubMed ID: 27784991
[TBL] [Abstract][Full Text] [Related]
9. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
Cheow WS; Ng ML; Kho K; Hadinoto K
Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.
Karimi K; Katona G; Csóka I; Ambrus R
J Pharm Biomed Anal; 2018 Jan; 148():73-79. PubMed ID: 28965047
[TBL] [Abstract][Full Text] [Related]
11. Novel dry powder inhaler formulation containing antibiotic using combined technology to improve aerodynamic properties.
Ambrus R; Benke E; Farkas Á; Balásházy I; Szabó-Révész P
Eur J Pharm Sci; 2018 Oct; 123():20-27. PubMed ID: 30016647
[TBL] [Abstract][Full Text] [Related]
12. Optimization of Ciprofloxacin Hydrochloride Spray-Dried Microparticles for Pulmonary Delivery Using Design of Experiments.
Razuc M; Piña J; Ramírez-Rigo MV
AAPS PharmSciTech; 2018 Oct; 19(7):3085-3096. PubMed ID: 30105497
[TBL] [Abstract][Full Text] [Related]
13. Steroid-decorated antibiotic microparticles for inhaled anti-infective therapy.
Lee SH; Teo J; Heng D; Zhao Y; Ng WK; Chan HK; Tan RB
J Pharm Sci; 2014 Apr; 103(4):1115-25. PubMed ID: 24510431
[TBL] [Abstract][Full Text] [Related]
14. Ciprofloxacin HCl-loaded calcium carbonate nanoparticles: preparation, solid state characterization, and evaluation of antimicrobial effect against Staphylococcus aureus.
Maleki Dizaj S; Lotfipour F; Barzegar-Jalali M; Zarrintan MH; Adibkia K
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):535-543. PubMed ID: 27012878
[TBL] [Abstract][Full Text] [Related]
15. Holistic Study Design Following Quality by Design Approach for Fabrication of Hybrid Polymeric Nanoparticulate Based Dry Powders as Carriers for Ciprofloxacin.
Ambrus R; Csóka I; Fenyes E; Orosz L; Sarkadi ÁN; Burián K; Kókai D; Mukhtar M
J Pharm Sci; 2024 Jul; 113(7):1946-1959. PubMed ID: 38643899
[TBL] [Abstract][Full Text] [Related]
16. A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart.
Tran TT; Vidaillac C; Yu H; Yong VFL; Roizman D; Chandrasekaran R; Lim AYH; Low TB; Tan GL; Abisheganaden JA; Koh MS; Teo J; Chotirmall SH; Hadinoto K
Int J Pharm; 2018 Aug; 547(1-2):368-376. PubMed ID: 29886096
[TBL] [Abstract][Full Text] [Related]
17. In vivo efficacy of a dry powder formulation of ciprofloxacin-copper complex in a chronic lung infection model of bioluminescent Pseudomonas aeruginosa.
Tewes F; Bahamondez-Canas TF; Moraga-Espinoza D; Smyth HDC; Watts AB
Eur J Pharm Biopharm; 2020 Jul; 152():210-217. PubMed ID: 32442738
[TBL] [Abstract][Full Text] [Related]
18. Storage stability of inhalable, controlled-release powder formulations of ciprofloxacin nanocrystal-containing liposomes.
Khatib I; Ke WR; Cipolla D; Chan HK
Int J Pharm; 2021 Aug; 605():120809. PubMed ID: 34144139
[TBL] [Abstract][Full Text] [Related]
19. New aerosol formulation to control ciprofloxacin pulmonary concentration.
Lamy B; Tewes F; Serrano DR; Lamarche I; Gobin P; Couet W; Healy AM; Marchand S
J Control Release; 2018 Feb; 271():118-126. PubMed ID: 29277683
[TBL] [Abstract][Full Text] [Related]
20. Preparation and Characterization of Doripenem-Loaded Microparticles for Pulmonary Delivery.
Yildiz-Peköz A; Akbal O; Tekarslan SH; Sagirli AO; Mulazimoglu L; Morina D; Cevher E
J Aerosol Med Pulm Drug Deliv; 2018 Dec; 31(6):347-357. PubMed ID: 29877747
[No Abstract] [Full Text] [Related]
[Next] [New Search]
